The expansion aims to meet the company’s rapidly growing need for in-house biologics manufacturing, with an emphasis on ...

Just months after facing a rejection in the US, the bispecific antibody odronextamab (Ordspono) has been approved by the ...

An international collaboration led by Hilleman Laboratories has confirmed the launch of a new oral cholera vaccine called ...

Microbiotica has received the green light from EU and UK regulatory authorities to start phase 1b studies for its microbiome ...

Results from a phase 2 trial of the candidate schizophrenia drug, currently known as NBI-1117568, show that it met the ...

ImmPACT Bio has received FDA clearance to start clinical trials for its CD19/CD20 bispecific CAR-T cell therapy in multiple ...

The US FDA has granted emergency use authorization to several updated COVID-19 vaccines against a new viral strain that is ...

Recent advancements in injectable hydrogels are setting the stage for a new era in tissue engineering and regenerative ...

Eisai and Biogen’s new Alzheimer’s treatment, lecanemab, received a green light from UK regulators, marking a significant ...

The US FDA has granted approval to Niktimvo for the treatment of chronic graft-versus-host disease, a serious immune ...

As antibody-drug conjugates (ADCs) continue to heat up in the industry, Adcendo of Denmark has gained the global rights from ...

A team of scientists from the universities of Glasgow and Tel Aviv has developed a groundbreaking method to transform the ...